UNSPSC 85724051: Supplement left ankle joint with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left ankle joint with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SUG47Z

UNSPSC 85724051 Supplement left ankle joint with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under state and local procurement. The code describes a specific orthopedic surgical procedure, but the recent opportunities posted under this code do not align with the nominal scope. Instead, the posted solicitations cover independent medical evaluation services for pension disability determinations, surgical benefit carve-out management for employee health plans, occupational medical surveillance, specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve orthopedic implant procedures or tissue-bank procurement. The mismatch suggests the code may have been applied incorrectly in tagging these opportunities, or the source reflects tagging errors rather than genuine procurement demand for the procedure itself.

State and local bodies posting under this code include a municipal retirement office (City of Phoenix), a city employee benefits program (City of Long Beach), a state transportation agency (Washington State Department of Transportation), a county juvenile probation department (Harris County), a county benefits consortium (Collier County), and a county health system (County of Santa Clara). Geographic representation spans Arizona, California, Washington State, Texas, and Florida. The recent opportunities are distributed across multiple service lines with no concentration in orthopedic surgery or implant supply; accordingly, this code does not present a coherent procurement stream for vendors offering tissue substitutes or surgical implant services.